Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drugstore and pharmacy benefits giant CVS Caremark (CVS -0.17%) earned a coveted five-star ranking.
With that in mind, let's take a closer look at CVS and see what CAPS investors are saying about the stock right now.
CVS facts
|
| |
|---|---|
|
Headquarters (founded) |
Woonsocket, R.I. (1892) |
|
Market Cap |
$64.3 billion |
|
Industry |
Drug retail |
|
Trailing-12-Month Revenue |
$120.1 billion |
|
Management |
CEO Larry Merlo (since 2011) CFO David Denton (since 2010) |
|
Return on Equity (average, past 3 years) |
9.7% |
|
Cash/Debt |
$1.2 billion / $10.0 billion |
|
Dividend Yield |
1.8% |
|
Competitors |
Express Scripts (ESRX) Walgreen (WBA -0.11%) Wal-Mart Stores (WMT 1.02%) |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 1,749 members who have rated CVS believe the stock will outperform the S&P 500 going forward.
Just last week, one of those Fools, brenoboyle, succinctly summed up the CVS bull case for our community: "Attractive valuation, buybacks, increased prescription drug coverage, patent cliff increases generics for which CVS has better margins and aging population."
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
